CVE-2017-1604

Description

IBM Maximo Anywhere 7.5 and 7.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 132851.

Category

5.4
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.27%
Vendor Advisory ibm.com Vendor Advisory ibmcloud.com
Affected: IBM Maximo Anywhere
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/132851 vdb entry vendor advisory
http://www.ibm.com/support/docview.wss?uid=swg22011883 vendor advisory
http://www.securityfocus.com/bid/103126 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-1604?
CVE-2017-1604 has been scored as a medium severity vulnerability.
How to fix CVE-2017-1604?
To fix CVE-2017-1604, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-1604 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-1604 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-1604?
CVE-2017-1604 affects IBM Maximo Anywhere.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.